Related Experiment Video
Updated: May 29, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia
Guillermo Gonzalez-Burgos1, Kenneth N Fish, David A Lewis
1Translational Neuroscience Program, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. gburgos@pitt.edu
Neural Plasticity
|September 10, 2011
Summary
Schizophrenia may stem from impaired GABA signaling, disrupting neural synchrony and cognitive function. Targeting these GABA pathways offers potential new treatments for cognitive deficits in schizophrenia.
Area of Science:
- Neuroscience
- Psychiatry
- Cellular Biology
Background:
- Schizophrenia is a brain disorder characterized by cognitive deficits impacting daily functioning.
- Limited understanding of schizophrenia pathophysiology exists, but postmortem studies indicate GABA-mediated synaptic transmission deficits.
- GABA transmission is crucial for synchronized network oscillations, essential for cognitive function.
Purpose of the Study:
- To review recent studies on GABA transmission and network oscillations in schizophrenia.
- To explore mechanisms of GABA-mediated synchronization, focusing on parvalbumin-positive GABA neurons.
- To identify potential therapeutic interventions for cognitive deficits in schizophrenia.
Main Methods:
- Literature review of recent studies on GABA transmission and network oscillations.
- Analysis of models for GABA-mediated synchronization of neural activity.
- Focus on parvalbumin-positive GABA neurons and their role in neural synchrony.
Main Results:
- Recent studies suggest alterations in GABA transmission and network oscillations in schizophrenia.
- Parvalbumin-positive GABA neurons, altered in schizophrenia, are linked to neural synchrony production.
- Impaired GABA signaling disrupts gamma oscillations, contributing to cognitive deficits.
Conclusions:
- GABA synapse dysfunction is a potential cause of cognitive deficits in schizophrenia.
- Alterations in GABA signaling and network oscillations are implicated in schizophrenia pathophysiology.
- Targeting GABA signaling pathways may lead to novel therapeutic strategies for schizophrenia.
Related Concept Videos
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...